Holen Sie sich die Stockscreener-App
7.26
11.89%
-0.98
Vorhandelsmarkt:
7.22
-0.04
-0.55%
Finanzdaten der Eikon Therapeutics Inc-Aktie (EIKN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 |
| Periodenlänge | 3 Monate | 3 Monate |
| Operating Expenses |
6.94%
93.39
|
87.34 |
| Operating Income/Loss |
6.94%
-93.39
|
-87.34 |
| Net Interest Income/Expense |
15.00%
5.037
|
4.38 |
Net Income/Loss
|
6.57%
-88.41
|
-82.96 |
| Basic Average Shares |
60.66%
54.14
|
33.70 |
| Diluted Average Shares |
60.66%
54.14
|
33.70 |
| Basic Earnings Per Share |
33.74%
-1.63
|
-2.46 |
| Diluted Earnings Per Share |
33.74%
-1.63
|
-2.46 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):